ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 126 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $65,000 | -71.0% | 23,014 | -61.9% | 0.01% | -66.7% |
| Q1 2018 | $224,000 | +28.0% | 60,378 | -0.6% | 0.02% | +157.1% |
| Q4 2017 | $175,000 | -74.0% | 60,752 | -59.4% | 0.01% | -89.1% |
| Q3 2017 | $673,000 | +171.4% | 149,817 | +177.0% | 0.06% | +178.3% |
| Q2 2017 | $248,000 | -15.9% | 54,092 | -24.3% | 0.02% | -36.1% |
| Q4 2016 | $295,000 | -83.7% | 71,428 | -67.9% | 0.04% | -81.7% |
| Q3 2016 | $1,805,000 | +165.4% | 222,833 | +155.6% | 0.20% | +129.1% |
| Q2 2016 | $680,000 | +273.6% | 87,170 | +269.5% | 0.09% | +244.0% |
| Q1 2016 | $182,000 | -11.2% | 23,591 | -61.7% | 0.02% | -69.5% |
| Q4 2013 | $205,000 | – | 61,651 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |